Evidence map›Paper›PMID 31320698›Full record

ArticleScientific reports2019

Approaching Higher Dimension Imaging Data Using Cluster-Based Hierarchical Modeling in Patients with Heart Failure Preserved Ejection Fraction.

Yukari Kobayashi, Maxime Tremblay-Gravel, Kalyani A Boralkar, Xiao Li, Tomoko Nishi, Myriam Amsallem, Kegan J Moneghetti, Sara Bouajila, Mona Selej, Mehmet O Ozen and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yukari KobayashiDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States. yukariko@stanford.edu.
Maxime Tremblay-GravelDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Kalyani A BoralkarDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Xiao LiDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Tomoko NishiDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Myriam AmsallemDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Kegan J MoneghettiDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Sara BouajilaDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Mona SelejMedical Director, Franchise, Medical Affairs Strategy, Actelion Pharmaceuticals US, Inc South, San Francisco, California, United States.
Mehmet O OzenStanford Cardiovascular Institute, Stanford, CA, United States.
Utkan DemirciStanford Cardiovascular Institute, Stanford, CA, United States.ORCID http://orcid.org/0000-0003-2784-1590
Euan AshleyDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.ORCID http://orcid.org/0000-0001-9418-9577
Matthew WheelerDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Kirk U KnowltonIntermountain Medical Center Intermountain Heart Institute, Salt Lake City, UT, United States.
Tatiana KouznetsovaResearch Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences, Leuven, Belgium.
Francois HaddadDivision of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure with preserved ejection fraction (HFpEF) is a major cause of morbidity and mortality, accounting for the majority of heart failure (HF) hospitalization. To identify the most complementary predictors of mortality among clinical, laboratory and echocardiographic data, we used cluster based hierarchical modeling. Using Stanford Translational Research Database, we identified patients hospitalized with HFpEF between 2005 and 2016 in whom echocardiogram and NT-proBNP were both available at the time of admission. Comprehensive echocardiographic assessment including left ventricular longitudinal strain (LVLS), right ventricular function and right ventricular systolic pressure (RVSP) was performed. The outcome was defined as all-cause mortality. Among patients identified, 186 patients with complete echocardiographic assessment were included in the analysis. The cohort included 58% female, with a mean age of 78.7 ± 13.5 years, LVLS of -13.3 ± 2.5%, an estimated RVSP of 38 ± 13 mmHg. Unsupervised cluster analyses identified six clusters including ventricular systolic-function cluster, diastolic-hemodynamic cluster, end-organ function cluster, vital-sign cluster, complete blood count and sodium clusters. Using a stepwise hierarchical selection from each cluster, we identified NT-proBNP (standard hazard ratio [95%CI] = 1.56 [1.17-2.08]) and RVSP (1.37 [1.09-1.78]) as independent correlates of outcome. When adding these parameters to the well validated Get with the Guideline Heart Failure risk score, the Chi-square was significantly improved (p = 0.01). In conclusion, NT-proBNP and RVSP were independently predictive in HFpEF among clinical, imaging, and biomarker parameters. Cluster-based hierarchical modeling may help identify the complementally predictive parameters in small cohorts with higher dimensional clinical data.

Indexed as

AgedBiomarkersDiastoleEchocardiographyFemaleHeart FailureHeart VentriclesHospitalizationHumansMalePrognosisStroke VolumeVentricular Function, LeftBiomarkers

Identifiers

PMID31320698
PMCPMC6639369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.